R

Regeneron

12286 employees

Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.

Investor insights

Sectors invested in

Biotechnology5
Therapeutics3
Medical2
Data management1
RNAi1
Drug Development1
Health Care1
Pharmaceutical1
Biotech1
Pharmaceuticals1
Biopharma1
Rare Diseases1
Cloud Computing1
Software1
Medical Device1
Life Science1
Computational biology1
Clinical-grade security1
Cloud computing1
Electronic Health Records1

Funding rounds participated in

$68M sweet spot round size

Most of their 6 investments are in rounds between $30M and $100M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Biopharma

Date founded

1988

Investments made

S

Sonoma Biotherapeutics raised $30M on March 28, 2023

Investors: Regeneron

V

Vyriad raised $30M on May 17, 2022

Investors: Mayo Clinic, Center for Innovation, Mirae Asset MAPS Global Investments Co., Ltd and Regeneron

D

DNAnexus raised $100M on June 9, 2020

Investors: First Round Capital, GV, Northpond Ventures, Perceptive Advisors, Foresite Capital and Regeneron

U

Undisclosed raised $80M on September 2, 2019

Investors: Pontifax Venture Capital, OrbiMed Advisors and Regeneron

A

Alnylam Pharmaceuticals raised $800M on April 8, 2019

Investors: Regeneron

D

Decibel Therapeutics raised $55M on June 19, 2018

Investors: S-Cubed Capital, S.R. One Ltd, GV, Bessemer Venture Partners, Foresite Capital, The Longevity Fund, Third Rock Ventures and Regeneron

FAQ